SUBSCRIBE
SUBSCRIBE

GLP-1

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Biotech Bay
Is This One Drug Enough To Revive Hope In Eli Lilly and Company’s Pipeline?
March 5, 2014
 · 
1 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
BioForest
Pacific Biomarkers, Inc. Announces Ultra-Sensitive Assay Services To Detect Drug-Entities And Biomarkers In Human And Animal Sera
February 27, 2014
 · 
2 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Biotech Bay
Clock Is Ticking For AstraZeneca PLC
February 26, 2014
 · 
1 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Arginine Could Treat Early Symptoms of Type 2 Diabetes, University of Copenhagen Study
September 13, 2013
 · 
1 min read
Hormone Combination Shows Promise in the Treatment of Obesity and Diabetes, Imperial College London Study
March 19, 2013
 · 
1 min read
BioMidwest
University of Minnesota Medical School Study Suggests Glucagon-Like Peptide-1 Receptor Agonists Related to Adolescent Weight Loss
February 5, 2013
 · 
1 min read
Pharm Country
Too Little Sleep Spurs Appetite-Boosting Hormones, Columbia University Study
December 10, 2012
 · 
1 min read
Biotech Bay
Sleep Duration Affects Hunger Differently in Men and Women, American Academy of Sleep Medicine Reveals
November 1, 2012
 · 
1 min read
What Moves Biotech Stocks? <b>Ed Arce</b> Has Answers
What Moves Biotech Stocks? Ed Arce Has Answers
October 22, 2012
 · 
18 min read
Genetown
GI Dynamics Advances Weight Loss Device
March 29, 2011
 · 
7 min read
Load More
PRESS RELEASES
Press Releases
Ascletis Announces Co-formulation of ASC36, Once-Monthly Next-Generation Amylin Receptor Agonist and ASC35, Once-Monthly Next-Generation GLP-1R/GIPR Dual Agonist for Clinical Development
November 12, 2025
 · 
6 min read
Press Releases
Neurogastrx Announces NG101 Phase 2 Clinical Study Demonstrating Significant Reductions in Nausea and Vomiting Induced by GLP-1 Receptor Agonist Semaglutide
November 10, 2025
 · 
4 min read
Press Releases
Structure Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
November 6, 2025
 · 
10 min read
Press Releases
OrsoBio to Present Clinical and Preclinical Data on Mitochondrial Protonophore Portfolio for Obesity at ObesityWeek® 2025
November 5, 2025
 · 
7 min read
Press Releases
Coya Therapeutics Announces That Its Combination LD IL-2/GLP-1 RA Candidate (COYA 303) Demonstrated Potent Systemic and Brain Anti-Inflammatory Efficacy In Vivo
November 5, 2025
 · 
7 min read
Press Releases
Veloxity Labs Acquires SCIEX Accurate Mass Spectrometer, the ZenoTOF 8600 System, to Accelerate Peptide and Complex Bioanalysis
November 5, 2025
 · 
4 min read
Press Releases
Hengrui Pharma and Kailera Therapeutics Announce Additional Data from Phase 3 Obesity Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531
November 5, 2025
 · 
7 min read
Press Releases
Omada Health to Present Real-World Evidence at ObesityWeek 2025 Demonstrating Enhanced Outcomes for Current and Former GLP-1 Users
November 5, 2025
 · 
5 min read
Press Releases
Aion Medicines Presents Data at ObesityWeek Demonstrating Ultra-long-acting Pharmacokinetics and Pharmacodynamic Effects of AM-710, a Potential Best-in-class GLP-1 Receptor Agonist and the Longest Acting Incretin Identified to Date
November 4, 2025
 · 
3 min read
Press Releases
Immunis Publishes Research Showing Body Fat Loss and Reversal of Liver Steatosis and Fibrosis, While Increasing Lean Muscle Mass, in Aged Models
November 2, 2025
 · 
3 min read
Press Releases
Currax Pharmaceuticals to Spotlight New Research at ObesityWeek® 2025 Highlighting Craving Control, Behavioral Adherence, and Subpopulation Outcomes with CONTRAVE®
October 29, 2025
 · 
10 min read
Press Releases
BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market
October 28, 2025
 · 
5 min read
Press Releases
Biomea Fusion Announces First Patient Dosed in Phase I Study of BMF-650 a Next-Generation Oral GLP-1 Receptor Agonist
October 28, 2025
 · 
6 min read
Press Releases
Innovent’s Mazdutide Shows Superiority in Glycemic Control with Weight Loss over Semaglutide in a Head-to-head Phase 3 Clinical Trial DREAMS-3
October 27, 2025
 · 
9 min read
Press Releases
Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity
October 21, 2025
 · 
7 min read
Press Releases
FDA approves Novo Nordisk’s oral semaglutide for cardiovascular (CV) risk reduction in adults with type 2 diabetes who are at high risk, including those who have not had a prior CV event
October 20, 2025
 · 
12 min read
Press Releases
Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Once-Monthly Subcutaneous Depot Treatment Formulation of Small Molecule GLP-1R Agonist ASC30 for Obesity
October 19, 2025
 · 
4 min read
Press Releases
Lilly’s oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes
October 16, 2025
 · 
9 min read
Press Releases
Alpha Genesis Expands GLP Capacity Following Multi-Million-Dollar Investment to Accelerate IND-Enabling Nonhuman Primate Studies
October 15, 2025
 · 
3 min read
Press Releases
Ascletis Selects a Best-In-Class Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for Clinical Development
October 13, 2025
 · 
6 min read
Load More